MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma

Overview of attention for article published in Frontiers in oncology, September 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 6,515 followers.

New research: MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma: Long-term survival in oesophageal squamous cell carcinoma (ESCC) is related with pathological… https://t.co/

01 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.